The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 17 , ISSUE 10 ( October, 2016 ) > List of Articles

RESEARCH ARTICLE

Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: An Immunohistochemical Study

Javed Khan, B Vikas Prasad, Gauri S Kakatkar, Preet Jain, Meetu Jain, Maulik Patel

Citation Information : Khan J, Prasad BV, Kakatkar GS, Jain P, Jain M, Patel M. Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: An Immunohistochemical Study. J Contemp Dent Pract 2016; 17 (10):857-860.

DOI: 10.5005/jp-journals-10024-1944

Published Online: 01-10-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction

Oral squamous cell carcinoma (OSCC) is one of the most common types of malignancy affecting the orafacial region and with a high mortality rate. The fact that stroma of the tumor modulates and facilitates the progression and metastasis of the malignancy has been shown in the past studies. The cells of the activated stroma that are responsible for the progression and metastasis of the tumor are the fibroblasts having smooth muscle properties. These myofibroblasts are said to secrete numerous inflammatory mediators and factors which are said to play a crucial role in tumor progression. Therefore, we evaluated the presence of myofibroblasts in OSCC, by immunohistochemistry using alpha smooth muscle actin (α-SMA) antibody.

Materials and methods

We evaluated a total of 50 biopsy specimens from the archives of the oral pathology, where 20 specimens out of 50 were of well-differentiated OSCC (WDOSCC), 20 were of poorly differentiated OSCC (PDOSCC), and 10 were of normal healthy controls. All the specimens were stained by immunohistochemically using with monoclonal antihuman α-SMA. Etemad-Moghadam et al method was used for assessing the myofibroblast distribution. Staining index was evaluated for the groups and compared. All the results were analyzed by Statistical Package for the Social Sciences (SPSS) software.

Results

The mean percentage of myofibroblasts score for WDOSCC and PDOSCC were 2.88 and 2.92 respectively. The mean staining intensity score in WDOSCC and PDOSCC were 2.88 and 2.55 respectively. Statistically significant results were obtained while comparing the final staining index score between the OSCC group and normal control group. No significant correlation could be obtained while comparing the mean staining index score in between WDOSCC and PDOSCC.

Conclusion

Malignant epithelium might induce the adjacent stromal tissue to produce myofibroblasts. These specialized cells may be utilized as therapeutic targets for the treatment of OSCC.

Clinical significance

Proliferation of myofibroblasts may be used as a stromal marker of premalignancy and malignancy.

How to cite this article

Prasad BV, Kakatkar GS, Jain P, Jain M, Patel M, Khan J. Expression of Myofibroblasts in Oral Squamous Cell Carcinoma: An Immunohistochemical Study. J Contemp Dent Pract 2016;17(10):857-860.


PDF Share
  1. Oral cancer and precancerous lesions. CA Cancer J Clin 2002 Jul-Aug;52(4):195-215.
  2. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 2005 Oct;15(5):329-341.
  3. Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts. Am J Pathol 2005 Aug;167(2):475-488.
  4. The microenvironment of the tumourhost interface. Nature 2001 May 17;411(6835):375-379.
  5. Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity. J Oral Pathol Med 2011 Mar;40(3):208-213.
  6. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999 Jul;277(1 Pt 1):C1-C9.
  7. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004 48(5-6):509-517.
  8. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007 Dec;51(6):849-853.
  9. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008 Nov 15;123(10):2229-2238.
  10. Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A. Oral Oncol 2011 Sep;47(9):840-846.
  11. Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004 Feb 23;90(4):822-832.
  12. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006 Aug;5(15):1597-1601.
  13. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 2008 May;44(5):509-517.
  14. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2012 Sep 1;17(5):e733-e738.
  15. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 2009 Sep;38(8):639-643.
  16. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma . an immunohistochemical study. J Cancer Res Ther 2015 Oct-Dec;11(4):893-898.
  17. Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. J Clin Diagn Res 2014 Apr;8(4):ZC14-ZC17.
  18. Myofibroblast stromal presence and distribution in squamous epithelial carcinomas, oral dysplasia and hyperkeratosis. Asian Pac J Cancer Prev 2010;11(2):359-364.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.